OVER 50 per cent of people who have Long Covid feel better after having their coronavirus vaccination, a study has revealed.
While most people who contract Covid-19 recover in a few weeks, many have been left with long-term symptoms.
Read our coronavirus live blog for the latest updates
People who have Long Covid will often suffer from chronic fatigue and in some cases organ damage.
Data from the Office for National Statistics (ONS) suggests that 1.1 million people have self-reported symptoms of Long Covid.
The NHS opened up Long Covid clinics across the country to help those who have been hit with the condition, but a new study has found that many patients will experience relief after they have had their jab.
A study of over 800 people found that 56.7 per cent of those who participated felt an overall improvement in symptoms after receiving a coronavirus vaccine.
The participants were asked to wait a week to report their symptoms – so as not to confuse them with any possible side effects the vaccines may have produced.
So far in the UK over 36.7 million Brits have received a first dose of the coronavirus vaccine, with 20.2 having had a second.
There are three jabs currently being rolled out, the Pfizer/BioNTech, the Oxford/AstraZeneca and the Moderna.
The experts found that Long Covid sufferers who had the Pfizer or the Moderna jab reported the most improvements in symptoms, compared to those who had the Oxford jab.
People who had the Moderna jab said they saw an improvement in symptoms such as fatigue and brain fog.
The study found that after vaccination, 24.6 per cent had no change in symptoms, with 18.7 per cent reporting a deterioration.
The study has not yet been peer reviewed but suggests that vaccines help, in some part, to reset the immune system, telling the body to stop attacking itself.
Speaking to The Guardian, analysis author, Ondine Sherwood, from the patient advocacy group LongCovidSOS said the survey will reassure people that they would be “quite unlucky to have worsening symptoms”.
They added: “The data is very encouraging, but we don’t know how long the benefits last.”
Of the 812 participants, 130 people had received two jabs.
